Bandingkan Harga & Kinerja Bank Pan Indonesia Tbk (PNBN) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bank Pan Indonesia Tbk dan Organon Pharma Indonesia Tbk.: Bank Pan Indonesia Tbk diperdagangkan di Rp910 (kapitalisasi pasar 21,81 T, volume 24 jam 1,3 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Bank Pan Indonesia Tbk jauh lebih besar — sekitar 208,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PNBN | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 21,81 T | 104,4 M |
Volume | 1,3 jt | — |
Lot | 13,03 rb | — |
Perputaran | 1,18 M | — |
Harga Rata-rata | 903,58 | — |
Nilai Transaksi | 1,18 M | — |
Harga Ekuilibrium Indikatif | 910 | — |
Volume Ekuilibrium Indikatif | 1,43 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bank Pan Indonesia Tbk
PT Bank Pan Indonesia Tbk (the Bank) was established based on Deed No. 85 dated August 17, 1971 of notary Juliaan Nimrod Siregar gelar Mangaradja, S.H. Panin (Pan Indonesia) Bank was established by the merger of three small private banks. It was one of the first banks to be granted a foreign exchange license in 1972.
Selengkapnya di halaman PNBN →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
